Where in the world: A look at JHU's global endeavors in India

Image caption: The Ganges is held in deep reverence.

Students from India
  • CTY: 80
  • Undergraduate: 52
  • Graduate: 369
Alumni in India


Combating a TB epidemic

India accounts for one-quarter of the cases of tuberculosis infection globally, and nearly 40 percent of its population is infected with the disease, which kills 1.4 million people a year. Researchers in the School of Medicine's Center for Clinical Global Health Education and Center for TB Research—in collaboration with the National Institutes of Research in Tuberculosis, BJ Medical College, and other Indian institutions—are studying the impact of comorbidities such as diabetes mellitus, HIV, malnutrition, and host genetics on TB treatment outcomes in adults and children in India, and the impact of these factors on the risk of developing TB and transmitting the disease to household members. The team is also part of a large multicountry network that conducts clinical trials focused on TB/HIV treatment and prevention in Indian pregnant women and children. Also in India, a new study led by Bloomberg School researchers suggests that getting patients quickly evaluated by the right doctors can be just as effective at curbing tuberculosis as a new, highly accurate screening test.

Promoting vaccines

In partnership with Global Health Strategies' New Delhi office, the Bloomberg School's International Vaccine Access Center provides technical, policy, advocacy, and communications support for the implementation of new vaccines as part of a comprehensive approach to addressing two leading threats to children in India: pneumonia and diarrhea. It also has begun advocacy efforts around inactivated polio vaccine to help communicate its role in the global effort to eradicate the disease.

Healthy Birth spacing

More than 1.2 billion people live in India, which is expected to overtake China as the world's most populated country by 2020. Seeking an effective alternative to an extreme measure like sterilization, the Indian government has partnered with Jhpiego to give women access to a long-term, safe, and reversible family planning method: the postpartum IUD. Since 2010, 275,000 women have accepted the contraceptive device through Jhpiego-supported programs. Research has shown that family planning can not only help control population growth but avert a third of maternal deaths if couples space their pregnancies more than two years apart.

Raising the standard of health care

HCL Avitas and Johns Hopkins Medicine International began an affiliation in February to help raise the standard of health care in India through knowledge exchange and consulting arrangements. HCL Avitas will operate India's first nationwide networked multispecialty clinics, and Johns Hopkins Medicine experts will advise HCL Avitas on the development of clinical programs and assist in protocol development, medical affairs, quality improvement, risk management, patient safety, accreditations, and clinical facility design.

Chewing tobacco and oral cancer

The second-largest producer and third-largest consumer of tobacco, India has the world's largest incidence of oral cancer. Almost all states have banned the sale, production, and distribution of gutka (chewing tobacco), but anecdotal evidence and casual observation suggest that these bans are only partial in some states and that enforcement is lax. A study by the Johns Hopkins Center for Communication Programs will identify and assess critical policy implementation processes and outcomes across six states and assess the compliance with, and enforcement of, existing bans.

Tagged global health